Daschle Tells Lab Executives to Expect Cost Cuts as Part of Health Reform
Ex-Senate Majority Leader Predicts Democrats Will Aggressively Push Reform
In recent weeks, laboratory professionals got a ringside seat to hear a true Washington insider discuss key issues in healthcare reform. Former U.S. Senate Majority Leader Tom Daschle, told lab industry executives and pathologists that Congress faces three significant hurdles as it attempts to reform the healthcare system. The first—and perhaps most significant—hurdle involves costs, he said. Daschle is currently a Senior Policy Advisor at Alston and Bird, a law firm in Washington, D.C.
“Cost is a huge political factor,” stated Daschle during a recent audio conference conducted by the American Clinical Laboratory Association (ACLA) on June 24. “Of all of the factors, cost is driving this debate as much if not more than any [other single factor]. We are looking at an investment cost of about $1 trillion to put this new infrastructure in place and that is an issue of great concern.” Daschle explained that the other two hurdles are quality of care and access to healthcare.
(more…)
